[ad_1]
The competitors watchdog has warned {that a} proposed merger between two healthcare expertise specialists would result in greater prices and “worse outcomes for the NHS and finally sufferers and UK taxpayers”.
The Competition and Markets Authority (CMA) discovered the £1.2bn deal for the US agency UnitedHealth to purchase British rival EMIS may scale back competitors to develop and provide digital and information analytics merchandise to the well being service.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased